BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12212117)

  • 1. [The effect of FHIT gene on renal cell carcinomas].
    Chen X; Shen PF; Chen ZC
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):457-9. PubMed ID: 12212117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal expression of the FHIT gene in human primary gastrointestinal cancers].
    Duan XM; Zhang GY; Wu ES
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):331-3. PubMed ID: 12205991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
    Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
    Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
    Hadaczek P; Siprashvili Z; Markiewski M; Domagala W; Druck T; McCue PA; Pekarsky Y; Ohta M; Huebner K; Lubinski J
    Cancer Res; 1998 Jul; 58(14):2946-51. PubMed ID: 9679951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FHIT gene is abnormal in tongue carcinoma cell line].
    Liu F; Wu J; Sun Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):472-5. PubMed ID: 14565016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FHIT gene is abnormal in Chinese lung cancers].
    Zhang J; Fu W; Zhang X
    Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):592-5. PubMed ID: 11715406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of FHIT expression in gastric carcinoma.
    Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
    Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas.
    Kvasha S; Gordiyuk V; Kondratov A; Ugryn D; Zgonnyk YM; Rynditch AV; Vozianov AF
    Cancer Lett; 2008 Jul; 265(2):250-7. PubMed ID: 18378390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FHIT gene is abnormal in laryngeal carcinoma].
    Fu W; Wu D; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):436-8. PubMed ID: 11776620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
    Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
    Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma.
    Luan X; Shi G; Zohouri M; Paradee W; Smith DI; Decker HJ; Cannizzaro LA
    Oncogene; 1997 Jul; 15(1):79-86. PubMed ID: 9233780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
    Eyzaguirre EJ; Miettinen M; Norris BA; Gatalica Z
    Mod Pathol; 1999 Oct; 12(10):979-83. PubMed ID: 10530564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
    Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
    Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Msh2 is not associated with FHIT deletion in breast carcinomas.
    Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(5):2591-5. PubMed ID: 12529969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
    Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
    J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant FHIT transcripts in human colorectal cancers.
    Lee SH; Lee SH
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
    Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.